| Aleksandra M Laput, MD | |
|
3555 S Val Vista Dr, Gilbert, AZ 85297-7323 | |
| (602) 933-0777 | |
| (602) 933-0755 |
| Full Name | Aleksandra M Laput |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 3555 S Val Vista Dr, Gilbert, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982657102 | NPI | - | NPPES |
| 25834088 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 37584 (Colorado) | Secondary |
| 208M00000X | Hospitalist | 48224 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aleksandra M Laput, MD 3200 E Camelback Rd, Ste 250, Phoenix, AZ 85018-2327 Ph: (602) 933-1814 | Aleksandra M Laput, MD 3555 S Val Vista Dr, Gilbert, AZ 85297-7323 Ph: (602) 933-0777 |
News Archive
During the first week of school closures in San Jose, state Sen. Jim Beall's office received more than a dozen phone calls from distressed parents and caregivers.
Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced the successful completion of patient enrollment in its STARS clinical study.
Symptoms of Parkinson's disease include tremor, loss of smell and neuropsychiatric problems. However, many people aren't diagnosed until their disease is well-advanced, which could limit their treatment options.
Scientists from the University of Southampton and Synairgen, a respiratory drug development company spun out from the University, can announce positive data from its Phase II clinical trial, into the effectiveness of the drug SNG001 (inhaled interferon beta) for asthma patients.
St. Jude Medical, Inc., a global medical device company, today announced the publication of results from an economic evaluation of the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which confirmed FFR-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease improves patient outcomes and offers cost-saving benefits to the U.S. healthcare system.
› Verified 6 days ago
Cindy A Duke, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3555 S Val Vista Dr, Gilbert, AZ 85297 Phone: 602-933-0777 Fax: 602-933-0755 | |
Tiana Hallberg, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3555 S Val Vista Dr, Gilbert, AZ 85297 Phone: 602-933-0777 Fax: 602-933-0755 | |
Dr. Amanda Jean Reynolds, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 3555 S Val Vista Dr, Gilbert, AZ 85297 Phone: 602-933-0777 Fax: 602-933-0755 | |
Dr. Santosh K. Rao, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2946 E. Banner Gateway Dr., Suite 450, Gilbert, AZ 85234 Phone: 480-264-3676 | |
Dr. Dereje Fikremariam Moti, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-543-2034 Fax: 480-543-2034 |